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Type I modular polyketide synthases (PKSs) produce polyketide
natural products by passing a growing acyl substrate chain
between a series of enzyme domains housed within a gigantic
multifunctional polypeptide assembly. Throughout each round of
chain extension and modification reactions, the substrate stays
covalently linked to an acyl carrier protein (ACP) domain. In the
present study we report on the solution structure and dynamics
of an ACP domain excised from MLSA2, module 9 of the
PKS system that constructs the macrolactone ring of the toxin
mycolactone, cause of the tropical disease Buruli ulcer. After
modification of apo ACP with 4′-phosphopantetheine (Ppant) to
create the holo form, 15N nuclear spin relaxation and paramagnetic
relaxation enhancement (PRE) experiments suggest that the
prosthetic group swings freely. The minimal chemical shift
perturbations displayed by Ppant-attached C3 and C4 acyl chains
imply that these substrate-mimics remain exposed to solvent at the
end of a flexible Ppant arm. By contrast, hexanoyl and octanoyl
chains yield much larger chemical shift perturbations, indicating
that they interact with the surface of the domain. The solution
structure of octanoyl-ACP shows the Ppant arm bending to allow
the acyl chain to nestle into a nonpolar pocket, whereas the
prosthetic group itself remains largely solvent exposed. Although
the highly reduced octanoyl group is not a natural substrate for
the ACP from MLSA2, similar presentation modes would permit
partner enzyme domains to recognize an acyl group while it is
bound to the surface of its carrier protein, allowing simultaneous
interactions with both the substrate and the ACP.
Key words: acyl carrier protein, mycolactone, NMR spectroscopy,
4′-phosphopantetheine, type I polyketide synthase.
INTRODUCTION
Type I modular polyketide synthases (PKSs) are large,
multi-domain complexes responsible for generating natural
products with a spectrum of medically important activities,
including antibiotic, anticancer, antifungal, antitumour and
immunosuppressive properties [1]. Like type I fatty acid synthases
(FASs), these systems consist of a series of covalently linked
enzymes that extend a polyketide substrate by two carbon atoms
and modify the functionality of the newly added building block
via reactions at the β-ketone site. In FAS systems the substrate
is cycled repeatedly between a single set of enzymes to produce
long, saturated acyl chains, but in the majority of modular PKS
systems each extension step is carried out in sequence by a distinct
set or ‘module’ of enzymes.
PKS extension modules comprise three domains essential for
constructing the product chain [2]: a small (∼10 kDa) acyl carrier
protein (ACP) to which the polyketide substrate is tethered via
thioester linkage to a 4′-phosphopantetheine (Ppant) prosthetic
group; an acyltransferase (AT), which selects an appropriate
extender unit (commonly malonate or methylmalonate as their
coenzyme A thioesters) for loading on to the ACP; and a
ketosynthase (KS), which accepts a polyketide chain from a
previous module and attaches the new extender unit by catalysing
a decarboxylative condensation reaction (Figure 1A). To
introduce chemical diversity into the polyketide product, modules
can contain additional enzyme domains [2]: a ketoreductase
(KR) that reduces the β-ketone group to an alcohol and may
also epimerize the adjacent α-centre; a dehydratase (DH), which
eliminates the β-hydroxy to form an α-β double bond; and an
enoyl reductase (ER) that reduces the resulting alkene, producing
a saturated β-methylene group (Figure 1A). The terminal module
of a PKS system normally contains a thioesterase (TE) domain,
which promotes release and often cyclization of the substrate. The
length and functionality of the final product is therefore defined
by the number, order and domain composition of modules within
the system [1].
The intuitive, linear, assembly-line nature of modular PKS
and similarly configured non-ribosomal peptide synthetase
(NRPS) systems make them attractive targets for combinatorial
biosynthesis and synthetic biology strategies [3,4]. Although
numerous new compounds have been generated by such
approaches, engineered PKS multi-enzyme complexes often
display reduced activity or result in undesirable product mixtures
[5,6]. A major limitation in overcoming such deficiencies is a poor
understanding of the interactions that occur within and between
modules. The role of the ACP is central to this question, since it
must present covalently tethered substrates to the active sites of
each enzymatic domain within its module, as well as a KS or a TE
in the subsequent module [7,8]. However, whether the ACP plays
an active role in this process or merely restricts free diffusion of
the substrate has not yet been fully established for type I PKS
systems [9,10].
Transitions between different module configurations may
restrict the access of an ACP to a subset of partner domains
during different phases of the reaction cycle [10], but from the
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Figure 1 Reaction scheme and module organization for the mycolactone PKS system
(A) Catalytic cycle for domains from the MLSA2 module. (B) Module organization for the three subunits of the mycolactone PKS system (MLSA1, MLSA2 and MLSB). The product of MLSA2 is
shown attached to its carrier protein domain. The structure of mycolactone is colour coded to match the subunits responsible for synthesizing each segment. DH domains predicted to be inactive are
shaded black.
point of view of the carrier protein three potential mechanisms
for identifying the appropriate active site can be envisaged: (i)
substrate-mediated modifications of ACP structure to promote
enzyme-specific protein–protein interactions; (ii) recognition of a
combination of the ACP surface and substrate chemistry; or (iii)
pure recognition of substrate chemistry by the catalytic domain in
the absence of specific interactions with the ACP. Identifying
which of these mechanisms is used to regulate interactions
between substrate-loaded ACPs and the various catalytic domains
will have important consequences for rational engineering of PKS
assembly lines to produce novel polyketide scaffolds.
Type II PKS systems consist of discrete domains, so their
acylated ACP domains can only interact with partner enzymes
in trans. Carrier proteins of this sort typically protect complex
substrate chains from contact with the solvent by sequestering
them inside a hydrophobic pouch to minimize premature
hydrolysis and unwanted side reactions [9,11]. In the case
of the Streptomyces coelicolor FAS ACP, solution structures
for a complete set of C6 reaction intermediates demonstrate
that although the global fold of the domain is retained, the
conformations of the thioester, the Ppant moiety and nearby
regions of the protein are subtly different [12]. These structural
changes could assist in selecting the correct active site for
the next step in the catalytic cycle. However, the type I FAS
and PKS ACP domains studied to date do not appear to bury
their substrates [13–16], so the same mode of conformational
programming may not apply. Similarly, the ‘switchblade’ [17] or
‘chain-flipping’ [11] paradigms required to explain how a partner
enzyme can gain access to a reduced acyl chain that is sequestered
inside the hydrophobic core of a type II ACP domain may not
be relevant to type I systems if ACP-tethered substrates are
continuously on display, sheltered by the quaternary architecture
of the surrounding module. Current investigations of substrate-
loaded NRPS aryl and peptidyl carrier protein domains from the
Type I yersiniabactin [18] and the Type II pyoluteorin [19] systems
are consistent with a more delicate mechanism: the distribution
of charge across the surface of the domain is modulated by
interactions with both the Ppant arm and the substrate in ways
that could favour productive encounters with specific partners.
Recent cryo-electron microscopy (cryo-EM) studies on the fifth
chain-extension module from the pikromycin PKS (Pik module
5) suggest that positioning of the ACP within a type I module
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
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may be driven by the identity of the substrate attached to the
Ppant arm [20,21]. ACP domains modified with substrate mimics
were found to dock on to the appropriate enzymatic domain for
the ensuing reaction within the module’s catalytic cycle, although
predominantly at distances too remote for the substrate to access
the relevant active sites [22]. Further, loading a polyketide chain
that mimicked the module’s final product caused the ACP to
protrude from the base of the module at a position thought to be
suitable for downstream transfer of the substrate to a subsequent
module or TE. Of the three mechanisms for ACP partner selection
suggested above, these results favour the second, as in most cases
both protein–protein interfaces and correct substrate chemistry
appear to be necessary for progression through the catalytic cycle
[10,20,21].
The PKS responsible for production of the Mycobacterium
ulcerans toxin mycolactone, the molecular cause of Buruli ulcer
[23], presents a particularly attractive system in which to study the
intricacies of modular PKS systems. Despite significant variations
in the length and chemistry of the substrate encountered at
each step, the mycolactone synthases display a remarkably high
sequence identity (>95%) between equivalent domains across 16
chain extension modules found in three protein chains: MLSA1,
MLSA2 and MLSB (Figure 1B) [24,25]. Such a high degree
of similarity between modules suggests either that enzymatic
domains from the mycolactone PKS are less discriminating (and
may therefore be good candidates for combinatorial biosynthesis
and synthetic biology), or that the few residues which do vary are
specific for particular features of natural substrates.
As a first step towards the biophysical characterization of
interactions between carrier protein and partner enzyme domains
from a canonical type I PKS module that contains a complete
reductive loop and a chain-releasing TE domain, we report here
studies of the solution structure and dynamics of mACP9, the
ACP domain from MLSA2, module 9 of the PKS system that
constructs the macrolactone ring of mycolactone (Figure 1B) [25].
We demonstrate that different substrate-mimics interact with the
surface of the ACP in distinct ways that could play a role in the
recognition of partner domains.
MATERIALS AND METHODS
Expression and purification of apo mACP9
The mACP9 sequence from the mlsA2 gene from Mycobacterium
ulcerans (Uniprot: Q6MZA5; residues 2050–2140) cloned into
pET28 (EMD Millipore) was transformed into competent
Escherichia coli Tuner (DE3) cells (EMD Millipore). His6-
tagged mACP9 was expressed at 15 ◦C for 16 h in 1 litre of
LB or M9 medium, prepared according to standard protocols
[26], with 30 μg/ml kanamycin (Sigma) for selection and
1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) (Sigma)
for induction. Isotopically labelled samples were prepared by
supplementing M9 with 15N ammonium chloride (Sigma) and
13C6-D-glucose (Cambridge Isotope Laboratories). Cells were
harvested at a 600 nm absorbance of 0.6, resuspended in lysis
buffer (50 mM sodium hydrogen phosphate, 300 mM sodium
chloride, pH 8.0) with 5 mM imidazole, 2.5 units/ml benzonase
nuclease (EMD Millipore) and Sigmafast EDTA-free protease
inhibitor cocktail (Sigma) and lysed using an Emulsiflex C5
homogeniser (Glen Creston).
The clarified lysate was passed through Ni-NTA resin (Qiagen),
washed twice with lysis buffer containing 30 mM imidazole
and eluted with lysis buffer containing 300 mM imidazole. The
eluted protein was exchanged into phosphate buffer (50 mM
sodium hydrogen phosphate, 150 mM sodium chloride, pH 7.5)
and the His6-tag was cleaved using restriction grade thrombin
(EMD Millipore). The released mACP9 was further purified by
size exclusion chromatography using an ¨Akta Purifier 10 system
and a Superdex 75 10/300 column (GE Healthcare) in phosphate
buffer. The sample was concentrated using 5000 MWCO Vivaspin
20 columns (Sartorius Stedim). The expression and purification
was monitored by SDS/PAGE (NuPAGE) 4–12% Bis-Tris gels
(Life Technologies) stained with InstantBlue (Expedeon). The
identity of the sample was confirmed by electrospray injection
mass spectrometry (ESI MS; Supplementary Table S1 and
Supplementary Figure S1).
Preparation of covalently modified forms of mACP9
Co-expression with Sfp to make 15N-labelled holo mACP9
The mACP9/pET28 plasmid and a pSU2718 plasmid [27] with the
Sfp gene cloned between the NdeI and SalI sites were transformed
into competent E. coli Tuner (DE3) cells (EMD Millipore). Apart
from addition of 34 μg/ml chloramphenicol (Sigma) to growth
media for selection of the pSU2718 plasmid, expression and
purification of the holo protein was identical with that of the apo
protein described above. The extent of modification of mACP9
was monitored by ESI MS (Supplementary Figure S2), and was
complete in all cases taken forward for further study.
Sfp-based addition of 4′-phosphopantetheine and acyl-phosphopantetheine
groups
In vitro loading reactions were performed on 500 μM apo ACP9
samples by incubation with 5 μM recombinant Sfp [28], 2 mM
coenzyme A or its derivatives malonyl, butyryl, 2-butenoyl,
β-hydroxybutyryl, acetoacetyl, hexanoyl or octanoyl CoA (all
Sigma) in pH 7.5 phosphate buffer with 10 mM magnesium
chloride at 20 ◦C for 1 h. 10 mM DTT was added when handling
coenzyme A and holo mACP9 to prevent disulfide bond formation
between exposed thiol groups. Samples were subjected to size
exclusion chromatography as described above prior to further
analysis. In each case, the identity and extent of modification was
monitored by ESI MS (Supplementary Figures S3–S9).
Methanthiosulfonate-based modification of the 4′-phosphopantetheine thiol
(1-Oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl) methane-
thiosulfonate (MTSL) or (1-acetoxy-2,2,5,5-tetramethyl-3-
pyrroline-3-methyl) methanethiosulfonate (ATSL) (Toronto
Research Chemicals), both dissolved in DMSO, were added
to holo mACP9 in a 10-fold molar excess at less than 1% of
the sample volume, then incubated at 20 ◦C for 16 h. n-Propyl
methanethiosufonate (PMTS) oil (Toronto Research Chemicals)
was added directly to holo mACP9 at a 20-fold molar excess and
at less than 0.2% of the final sample volume. All samples were
incubated at 20 ◦C for 16 h and then subjected to size exclusion
chromatography as described above prior to further analysis.
Full labelling was confirmed by ESI MS (Supplementary Figures
S10–S12).
NMR experiments for assignment and distance restraints
All samples for NMR spectroscopy were prepared at concen-
trations of 200–800 μM in phosphate buffer supplemented with
10% D2O (Sigma) and 0.0025% 3,3,3-trimethylsilylpropionate
(Sigma) in 5 mm Ultra-Imperial grade NMR tubes (Wilmad)
to a final volume of 600 μL. 10 mM DTT was added to
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
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holo samples. [1H,15N]-HSQC, 15N-TOCSY-HSQC, 15N-NOESY-
HSQC, HNCA, HNCOCA, HNCACB and CBCA(CO)NH
spectra were recorded at 283 K on a Bruker DRX500 spectrometer
equipped with a z-shielded gradient triple resonance probe,
using standard procedures [29]. 13C-NOESY-HSQC spectra were
recorded at 283 K on a Bruker Avance DRX800 spectrometer
equipped with a 5 mm TXI CryoProbe. All NMR spectra were
processed using the Azara package (www.ccpn.ac.uk/azara), then
analysed and assigned using CcpNmr Analysis software [30].
To compare resonance positions in [1H,15N]-HSQC spectra of
different mACP9 species, average chemical shift differences were
determined using the formula δav = {0.5(δH)2 + 0.1(δN)2}0.5
[31]. The threshold for a significant shift change (0.042 ppm) was
calculated as twice the S.D. of the differences in all data sets
remaining after eliminating outliers with differences greater than
two S.D. from the initial mean.
Determination of solution structures for apo and octanoyl-mACP9
All structures of apo mACP9 were calculated from extended
templates by simulated annealing using ARIA 2.3 [32], with
manual screening of ambiguous restraints. Backbone ϕ and ψ
dihedral angle restraints were determined from chemical shifts
using the DANGLE program [33]. NOE distance restraints
generated by the resonance assignment process and dihedral angle
restraints were fed as input. Nine iterations were performed, each
determining 20 structures, except for the final round, in which
100 were calculated, followed by refinement in explicit solvent
for the 20 lowest energy structures, all of which were selected for
the final ensemble, which contains no distance violations >0.5 Å
(1 Å = 0.1 nm) and includes >97% of residues in the ‘most
favoured’ and ‘allowed’ regions of the Ramachandran plot. The
atomic coordinates of the final ensemble for apo mACP9 were
deposited in the Protein Data Bank under ID code 5HVC; the
corresponding NMR assignments were deposited in the Biological
Magnetic Resonance Data Bank under accession code 30007.
Structures of octanoyl-mACP9 were calculated following
the method described above for the apo form. Ser2096 was
replaced with a modified serine residue in which an octanoyl-
phosphopantetheine group replaced the H atom. Topology
files for the modified serine residue were created using the
programs ACPYPE and ANTECHAMBER [34–36]. The atomic
coordinates of the final ensemble for octanoyl-mACP9 were
deposited in the Protein Data Bank under ID code 5HV8; the
corresponding NMR assignments were deposited in the Biological
Magnetic Resonance Data Bank under accession code 30006.
15N nuclear spin relaxation experiments
15N nuclear spin relaxation experiments were recorded using
standard procedures [29] at 283K on a Bruker DRX500
spectrometer. 15N T1 delays (ms): 10, 50, 100, 150, 250, 400,
550, 700, 850, 1000. 15N T2 delays (ms): 14.4, 28.8, 43.2, 57.6,
72.0, 86.4, 100.8, 155.2. The heteronuclear NOE reference and
saturation experiments were carried out in duplicate to allow an
estimation of the error. An initial τ c estimate was obtained from
the R2/R1 ratios for each residue [37]; the same procedure was used
to make site specific estimates of the local rotational correlation
time τ eff. The relaxation parameters were analysed with version
4 of the Modelfree program [38] using the strategy described
by Mandel et al. [39]. HN N bond vectors from the solution
structure of apo mACP9 were used for anisotropic diffusion tensor
modelling of relaxation data for both the apo and holo forms.
Paramagnetic relaxation enhancement experiments
1HN T2 experiments [40] were recorded with delays (ms): 0.002,
8, 16 (reference); 0.002, 8, 16, 24 (MTSL-labelled). The reference
sample was prepared by reducing the paramagnetic MTSL with
a 5-fold molar excess of ascorbic acid (Sigma) from a 200 mM
stock solution, added directly to the MTSL-labelled mACP9 NMR
sample and incubated at 25 ◦C for 2 h.
Circular dichroism spectroscopy
Thermal denaturation profiles were obtained by monitoring
the molar ellipticity [θ ] at 220 nm on an Aviv Model 410
circular dichroism spectrometer. Samples of mACP9 species
were prepared at 0.1 mg/ml in 20 mM sodium hydrogen
phosphate, 50 mM sodium fluoride, pH 7.5. [θ ] was recorded
at 1 ◦C increments ranging from 20 ◦C to 95 ◦C. The unfolded
state percentage was calculated using the formula F(T) =
{([θ ]max − [θ ]T)/([θ ]max − [θ ]min)} × 100, where [θ ]max is the
maximum observed value of [θ ], [θ ]min is the minimum observed
value and [θ ]T is the [θ ] recorded at temperature, T . The melting
temperature Tm was estimated from the inflexion point of the
normalized melting curves. Reported Tm values are the mean for
three repeat experiments.
RESULTS
Expression and purification of mACP9 species
mACP9, a protein fragment spanning residues 2050–2140 of the
MLSA2 subunit, was expressed with an N-terminal His6-tag,
as described in Materials and Methods. Following purification
using nickel affinity chromatography, the fusion tag was removed
by thrombin cleavage, leaving four non-native amino acid
residues originating from the expression vector (GSHM-) at
the N-terminus of the construct. Analytical size exclusion
chromatography indicated that apo mACP9 is monomeric in
solution (Supplementary Figure S13). Phosphopantetheinylation
of mACP9 was carried out in vivo by co-expression with Sfp, a
broad specificity phosphopantetheinyl transferase [28], resulting
in full conversion from the apo to the holo form according to ESI
MS (Supplementary Figure S2).
Solution structure of apo mACP9
The [1H,15N]-HSQC spectrum of apo mACP9 displayed well-
resolved, dispersed signals indicative of a structured protein
(Figure 2). Eighty-three of the 84 expected backbone amide
resonances were assigned; no signal was detected for His2077,
which is located in a flexible surface exposed loop. Single
resonances were observed for each backbone and side-chain
amide site, suggesting that the domain adopts a unique
conformation in solution.
A total of 2953 NOE-derived distance restraints, of which
1424 were unambiguously assigned, were used to calculate the
solution structure of apo mACP9. After water refinement, the final
ensemble comprising the 20 lowest energy structures (Figure 3A)
has a backbone coordinate RMSD of 0.6 Å for residues 2050–
2140, reducing to 0.4 Å over the sections of regular secondary
structure; further statistics are summarized in Table 1. The
compact, right-hand twisted helical bundle (Figure 3B) is typical
of carrier proteins from PKS, FAS and NRPS systems [9]. The
three main α helices (α1: 2056–2075; α2: 2096–2110 and α3:
2125–2137) are interspersed with two short helical turns (α2′:
2089–2092 and α3′: 2118–2121). The main helices span the long
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
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Figure 2 NMR spectroscopy
[1H,15N]-HSQC spectrum of apo mACP9, showing residue assignments for backbone amide
sites. Pairs of resonances from side-chain amide sites are connected using magenta lines.
Assignments for closely spaced signals are displayed in the inset panel.
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Figure 3 Solution structure of apo mACP9
(A) Backbone overlay for the final ensemble of 20 lowest energy structures, coloured from blue
at the N-terminus to red at the C-terminus (5HVC). (B) Ribbon representation of the lowest
energy structure.
axis of the domain, with α1 antiparallel to α2 and α3, whereas
the shorter turns are approximately perpendicular to the long axis.
Ser2096, the attachment point for Ppant modification, is positioned
at the opposite end of the domain to the two termini. The side
chain of Ser2096 projects out towards the solvent at the beginning
of helix α2.
The core of the calculated structure contains closely packed
hydrophobic side chains, with no evidence for the interior cavities
observed in type II ACP structures [9]. The exterior surface is
predominately composed of hydrophilic side chains, the only
exception being a small nonpolar patch adjacent to the attachment
serine, produced by Phe2120 from turn α3′ and two solvent-exposed
leucine side chains from helix α2 (Leu2097 and Leu2100). The
nonpolar surface of the α2 ‘recognition helix’ is a common
distinction observed between type I and type II ACPs, for which
the equivalent region, proposed to be critical for interactions with
partner enzymes, is rich in acidic residues [9]. In the mACP9
structure, helix α2 contains only one acidic residue, Glu2101; the
majority of charged residues, which are predominantly basic, are
located on a face created by α2, α3′ and α3, whereas the opposing
α1 face is relatively uncharged (Supplementary Figure S14).
Holo and acyl-loaded forms of mACP9
Backbone assignments for the apo form were transferred to
experiments recorded on a holo mACP9 sample and verified using
NOE connections. As noted for the apo form above, the number
of signals detected was consistent with population of a single
conformational state. Two additional peaks in the [1H,15N]-HSQC
spectrum of holo mACP9 were identified as amide signals from
N4 and N8 in the Ppant arm (Supplementary Figure S15). The
profile of average 1HN/15N chemical shift differences shown in
Figure 4A demonstrates that the majority of backbone amide
sites experience only minor perturbations in their electronic
environment (<0.03 ppm), suggesting that the structure of mACP9
changes little between the apo and holo forms. Significant
differences are observed for residues adjacent to the attachment
serine (Ile2094-Asn2104) and for sites towards the N-terminus of the
nearby α3′ turn (Thr2117-Asp2121).
In type II ACP domains, the α3′ turn can undergo a minor
structural rearrangement upon conversion to the holo form [9],
but analysis of 15N- and 13C-separated NOESY spectra recorded
on both apo and holo states of mACP9 revealed no significant
differences, even for residues that display δav values >0.05 ppm,
indicating that the backbone conformations of the two species
remain very similar. In a comparison of apo and holo forms of the
type I ACP from module 6 of the DEBS system, similar patterns
of chemical shift perturbation were proposed to be a consequence
of proximity to the attachment site, resulting from transient
interactions with the dynamic Ppant moiety [13]. Interestingly,
for mACP9 the magnitude of shift change does not have a simple
relationship to distance from the attachment serine. For example,
in the apo mACP9 structure the backbone amide proton (HN)
of Thr2117 is 10.5 Å from the side-chain O atom of Ser2096 and
possesses a δav of 0.16 ppm, whereas Lys2090 HN, which is 10.1 Å
away, shows a δav of only 0.01 ppm. Enhanced chemical shift
perturbations in the α3′ turn could indicate that the Ppant arm
has a preferred orientation towards this region. Alternatively,
the backbone amide sites of residues 2117–2121 are all close
to the side chain of Phe2120, which projects out from α3′ towards
the attachment serine. A subtle change in side-chain χ 1 rotamer
populations caused by intermittent contacts with the prosthetic
group could alter the ring current contribution to the chemical
shifts of nearby sites sufficiently to account for the observed shift
differences.
Additional derivatives were prepared by in vitro incubation of
apo mACP9 with Sfp and various acyl coenzyme A thioesters.
In this way malonyl, acetoacetyl, β-hydroxybutyryl, 2-butenoyl
and butyryl groups were loaded on to holo mACP9 to mimic
the various chemistries that occur during the reaction cycle of
the MLSA2 module for a C4 chain (Figure 1A; Supplementary
Figure S16). Comparison of the [1H,15N]-HSQC spectra of loaded
mACP9 species with that of the holo form reveals that short acyl
chains have little or no effect on the structure of the domain.
Polar malonyl, acetoacetyl and β-hydroxybutyryl modifications
yield only minor chemical shift differences (Figures 4B–4D), but
when nonpolar 2-butenoyl and butyryl groups are attached to the
prosthetic group small but significant (>0.06 ppm) perturbations
are observed for sites in the α3′ turn (Figures 4E and 4F).
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
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Table 1 Restraints and statistics for the solution structures of apo and octanoyl-mACP9
apo mACP9 Octanoyl-mACP9
NOE-based distance restraints
Intra-residue, sequential 705 406
Medium range (2 | i − j | 5) 244 280
Long range (| i − j | > 5) 183 330
Ambiguous 1707 454
Total 2839 1949
Other restraints
Hydrogen bond restraints 0 0
ϕ + ψ dihedral angles restraints 167 167
Coordinate precision*
Backbone RMSD (A˚) 0.61 +− 0.11 0.96 +− 0.19
Heavy atom RMSD (A˚) 1.17 +− 0.18 1.46 +− 0.24
Consistency (structure compared with restraints)
RMSD (A˚) from experimental distance restraints 0.032 +− 0.002 0.036 +− 0.006
RMSD (◦) from experimental dihedral angle restraints 1.97 +− 0.08 1.12 +− 0.08
Ramachandran plot
Most favoured 89.3% 91.1%
Allowed regions 8.1% 8.0%
Generously allowed regions 1.2% 0.7%
Disallowed regions 1.4% 0.3%
WHATIF structure Z-scores
First generation packing quality 1.09 +− 0.63 1.03 +− 0.59
Second generation packing quality 6.36 +− 1.72 5.63 +− 1.61
Ramachandran plot appearance − 3.60 +− 0.25 − 3.31 +− 0.32
χ 1/χ 2 rotamer normality − 4.04 +− 0.35 − 5.38 +− 0.51
Backbone conformation − 0.15 +− 0.42 − 0.10 +− 0.02
*Coordinate precision, Ramachandran statistics and Z-scores were determined between residues 2050 and 2140.
By contrast, longer, completely reduced hexanonyl and
octanoyl chains cause much larger (>0.10 ppm) shift changes
at backbone sites through the length of helix α2 to the end of the
α3′ turn (Figures 4G and 4H). A 12C/14N-filtered 13C-separated
NOESY-HSQC experiment on a sample in which the ACP domain
was uniformly 13C/15N-labelled but the Ppant and octanoyl groups
remained unlabelled revealed 26 NOE connections between the
protein and the acyl chain. Together with 1949 protein–protein
distance restraints, these were used to determine the solution
structure of octanoyl-mACP9. The final ensemble has a backbone
RMSD of 0.8 Å for residues 2054–2140 and the lowest energy
structure is very close to that obtained for the apo state of mACP9
(backbone RMSD 1.1 Å). As Figure 5A shows, the Ppant moiety
remains somewhat disordered (with a heavy atom RMSD of
3.4 Å), whereas the octanoyl group (heavy atom RMSD 1.3 Å)
becomes more ordered towards the tip, which inserts into a small
nonpolar pocket between helix α2 and the α2′ and α3′ turns.
Experiments following the change in mean residue ellipticity
at 222 nm as a function of temperature demonstrated that apo,
holo, hexanoyl- and octanoyl-mACP9 species all undergo two-
state unfolding transitions, with melting temperatures of 326 K,
332 K, 331 K and 330 K respectively (Supplementary Figure S17).
These results confirm earlier work on the type II FAS ACP from P.
falciparum, which showed that priming with Ppant enhanced the
thermal stability of the domain [41]. For mACP9, it is interesting
that further modification with hexanoyl and octanoyl groups had
minimal effects, rather than causing the melting temperature
to increase. This suggests that the bound state captured in the
solution structure of octanoyl-mACP9 is formed only transiently,
with a lifetime long enough to allow for magnetization transfer
effects when the substrate chain is close to the protein surface,
but leaving the undocked state sufficiently populated that the free
energy difference between the folded and denatured states of the
domain is hardly affected.
In summary, the attachment of C3 and C4 chains has only a
modest effect on the behaviour of the Ppant group, especially if
the acyl groups are polar, whereas longer nonpolar C6 and C8
chains exceed a threshold for more significant, but still transient,
interactions with a hydrophobic patch on the surface of the ACP
domain.
15N nuclear spin relaxation studies
To investigate the solution state dynamics of mACP9, nuclear spin
relaxation properties were measured for 15N-labelled amide sites
in both the apo and holo forms and analysed using the Lipari–
Szabo model-free approach (Figure 6; Supplementary Figure
S18). The data fitted best to an axially symmetric diffusion
tensor model with a Dpar/Dper ratio of 1.30 and overall rotational
correlation times of 10.3 ns and 10.4 ns for the apo and holo states,
respectively, consistent with a monomeric, globular 90 amino acid
domain at 283 K. In both the apo and holo states, backbone sites
were found to be predominantly rigid (mean order parameter S2 of
0.87 +− 0.10 for both), with the same five residues possessing more
dynamic S2 values (<0.70): Met2050 at the N-terminus; Leu2106
in α2; Leu2114 in the loop between α2 and α3′ and Gln2138 and
His2140 at the C-terminus. These similar relaxation properties
indicate that no functionally relevant changes in backbone
dynamics are induced on conversion of apo mACP9 to the holo
form.
In vivo phosphopantetheinylation allowed relaxation paramet-
ers to be measured for the two 15N-labelled amide sites in the
Ppant arm. Both nuclei displayed properties indicating elevated
levels of local motion relative to the rest of the protein (see
Table 2). For example, the heteronuclear NOE ratios for N4
( − 0.76) and N8 ( − 0.13) possessed the opposite sign to the
average value for holo protein backbone sites ( + 0.72 +− 0.13).
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
Structure and dynamics of a mycolactone PKS acyl carrier protein domain 1103
Δδ
av
 (p
pm
)
2050 2060 2070 2080 2090 2100 2110 2120 2130 2140
Residue number
0
0
0
0
0
0
0
0
0.25
0.50
0.25
0.50
0.25
0.50
0.25
0.50
0.25
0.50
0.25
0.50
0.25
0.50
0.25
0.50
2050 2060 2070 2080 2090 2100 2110 2120 2130 2140
α1 α2 α3α2’ α3’
A
B
C
D
E
F
G
H
*
ACP~S
O O
O
ACP~S
O O
ACP~S
O OH
ACP~S
O
ACP~S
O
ACP~S
O
ACP~S
O
apo ACP / holo ACP
Figure 4 Chemical shift differences between modified forms of mACP9
Underneath a schematic defining the boundaries of α-helices in the structure of apo mACP9, average chemical shift differences, δav, are plotted as a function of residue number. Differences are
shown between holo mACP9 and the (A) apo; (B) malonyl; (C) acetoacetyl; (D) hydroxybutyryl; (E) buten-2-oyl; (F) butyryl; (G) hexanoyl; and (H) octanoyl forms. Ser2096, the point of attachment
for the prosthetic group, is indicated with an asterisk.
15N R1 and R2 values for the Ppant sites were used to estimate
effective local rotational correlation times (τ eff) of 3.7 ns and
4.1 ns for N4 and N8, respectively [37]. The relaxation properties
of the Ppant sites were also analysed using the Lipari–Szabo
model-free approach together with data from the rest of the holo
state. As no structural data was available for the prosthetic group,
an isotropic rotational diffusion model was assumed, which fit the
data best using an overall correlation time of 10.9 ns and S2 order
parameter values of 0.07 and 0.13 for N4 and N8 respectively.
These low S2 values demonstrate that the Ppant moiety reorients
much more rapidly than the rest of the protein and that the arm
becomes significantly more dynamic as it extends outward from
its point of attachment at the side chain of Ser2096. This behaviour
is consistent with freely swinging motion in the prosthetic group,
a conclusion supported by the observation that HN4 and HN8
display only weak, intra-Ppant NOE connections in the 15N-
separated NOESY spectrum of holo mACP9. Our in vitro strategy
for preparing acyl-loaded mACP9 samples relied on reactions
between the apo protein and unlabelled coenzyme A derivatives;
as a consequence, we did not have the opportunity to measure
the relaxation properties of Ppant amide sites in acyl-ACP
species.
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A B C
Figure 5 Solution structures of octanoyl-ACP species
Ribbon representations, coloured from blue at the N-terminus to red at the C-terminus, for (A) octanoyl-mACP9 (5HV8); (B) octanoyl-actACP (2KGC); and (C) octanoyl-ACP from the S. coelicolor
FAS (2KOS). Stick representations of pantoate, β-alanine, cysteamine and octanoyl sections are coloured orange, red, magenta and blue, respectively.
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Figure 6 15N relaxation parameters for holo mACP9
Underneath a schematic defining the boundaries of α-helices in the structure of apo mACP9, NMR parameters for backbone and prosthetic group amide sites in the holo state are plotted as a function
of residue number for: (A) the 15N longitudinal relaxation rate, R1; (B) the 15N transverse relaxation rate, R2; (C) the {1H}-15N NOE ratio (I′/I0, where I′ is the intensity when the 1H spectrum has
been saturated and I0 is the intensity in the reference spectrum); and (D) the Lipari–Szabo the order parameter, S2. Bars shaded in grey correspond to values for the N8 (left) and N4 (right) sites of
the prosthetic group.
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Table 2 Dynamics parameters derived from 15N nuclear spin relaxation
experiments
State Species τ eff (ns)* NOE ratio
apo Backbone average 10.3 0.68
holo Backbone average 10.5 0.72
holo N4 3.7 –0.76
holo N8 4.1 –0.13
ATSL, major Backbone average 10.5 0.72
ATSL, major N4 6.3 0.00
ATSL, major N8 6.6 0.24
ATSL, minor Backbone average 10.6 0.79
ATSL, minor N4 5.3 0.00
ATSL, minor N8 5.4 0.20
*Determined using the equation τ eff = [(6R2/R1) − 7]0.5/(2ωN) [37].
Paramagnetic relaxation enhancement studies
The chemical shift perturbations observed on conversion of
mACP9 from the apo to the holo form could be interpreted as
evidence that the Ppant group prefers to populate conformations
that are oriented towards the α3′ turn, similar perhaps to those
captured in the ensemble of structures for octanoyl-mACP9. By
contrast, our 15N nuclear spin relaxation measurements suggest
that the prosthetic group is highly flexible, implying that the
arm samples multiple conformations in an isotropic fashion.
To investigate this issue further, the Ppant arm of holo mACP9
was modified with the paramagnetic spin label reagent MTSL.
Two reference samples were also prepared: one modified with
ATSL, with the nitroxyl moiety replaced by an acetyl group
(Supplementary Figure S16); and one in which the nitroxyl
radical of MTSL was reduced to a diamagnetic hydroxy group via
treatment with ascorbate. The ascorbate-reduced reference sample
showed only minor chemical shift perturbations compared with
non-MTSL-labelled holo mACP9 (Figure 7B), confirming that
any interactions between the MTSL label and mACP9 must be
similar to those observed for C4-loaded species.
Paramagnetic relaxation enhancements (PREs) were quantified
as the difference between 1HN transverse relaxation rates in
the spin-labelled sample and in the reduced reference sample
(R2,MTSL − R2,ref) [40]. In the paramagnetic sample, several
resonances exhibited greatly enhanced relaxation, to the extent
that accurate R2,MTSL measurements could not be made; to include
these sites in Figure 7C, the value of R2,MTSL − R2,ref was set to an
arbitrary maximum of 75 Hz. The relaxation enhancement profile
is similar to that observed for chemical shift perturbations between
the apo and holo forms (Figure 7A), with residues surrounding
the attachment serine and around the α3′ turn affected most. As
Figure 7H suggests, all amide signals from sites within 12.5 Å
of the O atom of Ser2096 were bleached or strongly broadened
(including those from N4 and N8 in the Ppant arm). Proline
residues lack an amide proton, so they are not probed by this
technique.
Modification with disulfide-linked groups
Unexpectedly, labelling of mACP9 with ATSL yielded a [1H,15N]-
HSQC spectrum in which several resonances were doubled
(Supplementary Figure S19), rendering the sample unsuitable for
use as a reference state for PRE experiments. ESI MS revealed that
the sample contained a single species at the expected molecular
mass (Supplementary Figure S11), suggesting that the two
forms detected by NMR correspond to distinct conformational
states rather than alternative modification products. None of
the doubled peaks coincide with resonances from the apo or
holo forms of mACP9, indicating that modification with ATSL
creates two significantly different conformations. All resolvable
doublets comprise a minor peak with chemical shifts close to the
corresponding holo signal (Figure 7D) and a major peak showing
a larger shift perturbation (Figure 7E), with an intensity ratio
of approximately 1:1.4. In zz-HSQC experiments, no chemical
exchange cross-peaks between resolved doublets were detected
(results not shown), implying that if the two states are capable
of interconverting, this must occur on a timescale slower than
0.5 s. As Figure 7I shows, sites that give rise to doublets
include those displaying the strongest PRE effects (Figure 7H),
the largest chemical shift differences between the apo and holo
forms (Figure 7G), and the most significant perturbations in 2-
butenoyl- and butyryl-loaded samples, but affect fewer sites than
those changed in an octanoyl-loaded sample. Amide signals from
the prosthetic group were also doubled and displayed relaxation
properties (τ eff values of 6.5 ns and 5.4 ns for the major and minor
forms, respectively; Table 2) intermediate between those of the
protein backbone (∼10.5 ns) and the more dynamic arm of the
holo species (∼3.9 ns). Consistent with these results, the HN4 and
HN8 sites in both forms exhibited more intense 1H-1H NOEs than
the holo state, although once again only intra-Ppant connections
were observed.
Aiming to mimic the length of a butyryl substrate chain, we
modified a sample of the holo domain using PMTS. The [1H,15N]-
HSQC spectrum of PMTS-modified mACP9 showed a single
set of resonances with chemical shift changes (Figure 7F) more
extensive than those observed for butyryl-mACP9 (Figure 4F), but
smaller than for either of the ATSL-modified forms (Figures 7D
and 7E). Together with an absence of peak doubling for the
reduced MTSL sample, these observations suggest that multiple
ATSL-mACP9 states are a property of the altered nitroxide
moiety rather than a consequence of the linkage mode, such as
conformational isomerism of the disulfide bond [42]. The most
likely explanation is that the ATSL-modified prosthetic group
populates two distinct conformers, both of which dock against the
surface of the ACP domain, differing perhaps in the orientation
of the acetoxy moiety (Supplementary Figure S16). Within the
Ppant group, motions are restricted compared with the freedom of
movement experienced in the holo state, but a significant degree of
flexibility is retained. Although ATSL is not a natural substrate for
mACP9, these results provide a further demonstration that longer
substrates can interact with the surface of a type I PKS ACP
domain. Evidence that the prosthetic group possesses moderately
restricted dynamics in both ATSL-loaded conformers is consistent
with the picture conveyed by the solution structure of octanoyl-
mACP9, in which the Ppant arm shows a degree of conformational
heterogeneity that decreases as the acyl group approaches the
protein surface.
DISCUSSION
Although a wide variety of carrier protein domains have
been studied previously [9], this report on MLSA2 from the
mycolactone system is the first to compare the solution structures
of both the apo and acyl-loaded forms of an ACP domain excised
from a canonical type I PKS module. The only other published
atomic resolution structure for an ACP from a type I modular
PKS is for the apo domain from module 2 of the DEBS system
(eryACP2), which lacks DH and ER domains [43]. EryACP2
shares 48% sequence identity with mACP9 and its overall fold is
highly similar, showing a backbone RMSD of 1.3 Å over residues
c© 2016 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
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Figure 7 Average shift difference and PRE parameters for acyl-mACP9 species
Underneath a schematic defining the boundaries of α-helices in the structure of apo mACP9, properties of disulfide-linked substrate mimics are plotted as a function of residue number. Average
chemical shift differences, δav, are shown between holo mACP9 and (A) the apo form; (B) the reduced MTSL form; (D) the ATSL minor form (doubled peaks only); (E) the ATSL major form; and (F)
the PMTS form. Panel (C) shows the PRE effects (defined as R2,MTSL – R2,ref) for MTSL-mACP9. Cartoons of the apo mACP9 structure below highlight the Ser2096 modification site in red and amide
sites that: (G) show significant shift changes between the apo and holo forms (green); (H) are bleached in the MTSL form (yellow); and (I) exhibit doubled resonances in ATSL-labelled mACP9
(blue). Small cream spheres indicate the nitrogen atoms of proline residues.
equivalent to Leu2054-His2140 (Supplementary Table S3); the three
main helices possess almost identical orientations, whereas the
connecting loops and helical turns display a greater degree of
variation. In contrast with the clustering of charged side chains
towards one face observed for mACP9, the distribution of positive
and negative charges is more even across the surface of eryACP2
(Supplementary Figure S14). The mACP9 structure also resembles
those of ACP domains from the CalE8 iterative type I PKS
(backbone RMSD 1.1 Å), the curacin trans-AT hybrid PKS/NRPS
system (1.5 Å), S. coelicolor type II FAS (1.8 Å), the actinorhodin
type II PKS (2.0 Å) and rat type I FAS (2.3 Å) (Supplementary
Table S3).
Some type II carrier proteins exhibit multiple slowly
exchanging structural forms in solution [44–46] although such
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heterogeneity is apparently not ubiquitous [18,47]. The single
sets of resonances observed in our [1H,15N]-HSQC experiments
demonstrate that the apo, holo and acyl-loaded forms of mACP9
each appear to adopt a single conformational state on the timescale
of milliseconds to seconds monitored by slow regime chemical
exchange. The 15N relaxation properties of the apo and holo
forms of mACP9 (Figure 6; Supplementary Figure S18) support
this conclusion, showing that backbone amide sites are rigid on
the sub-nanosecond and the micro- to milli-second timescales,
except for close to the N- and C-termini and in the long linker
region between helices α1 and α2. It therefore seems unlikely
that chemical modification of mACP9 species would manipulate
the populations of significantly different pre-existing protein
conformations in order to optimize their surface structures for
interactions with particular partner enzyme domains [44,48].
Similarly modest degrees of backbone flexibility have been
detected in inter-helical regions for the CalE8 [49] and frenolicin
type II PKS ACP domains [50].
The Ppant arms of holo ACP species adopt a spectrum of
dynamic states, ranging from tightly bound to the carrier protein
surface to freely swinging. For example, the prosthetic group
of the holo form of an atypical Geobacter metallireducens
ACP (GmACP3) is rigid, displaying S2 order parameter values
similar to those for structured backbone sites (∼0.8), together
with 23 Ppant-protein NOE connections [51]. The Plasmodium
falciparum type II FAS ACP (Pf ACP) represents the centre
ground, exhibiting two conformers in slow exchange due to
different docked orientations of the Ppant moiety; in both states
the prosthetic group is semi-rigid, with S2 values for N4 and N8
in the 0.1–0.5 range, but also 6 NOEs between the arm and the
protein surface [46]. The prosthetic group of frenolicin holo ACP
is at the high flexibility end of the scale, exhibiting chemical shifts
identical with those for free coenzyme A, low S2 values (∼0.1)
and no detectable Ppant-protein NOEs [50]. For holo mACP9,
Ppant group behaviour is close to this freely swinging extreme,
showing no evidence for NOEs to the protein surface and N4 and
N8 order parameter values of 0.07 and 0.13, respectively (Table 2),
consistent with the arm becoming progressively more dynamic as
it protrudes into the solvent.
Interestingly, backbone 1HN/15N chemical shift perturbations
appear to be less sensitive probes of protein/prosthetic group
interactions than Ppant 15N relaxation parameter measurements
or the detection of direct Ppant-protein NOE connections. For
mACP9, which possesses a highly dynamic arm, the largest
detected δav value between the apo and holo forms is ∼0.3 ppm
(Figure 4A), whereas the largest corresponding shift change
for the firmly bound GmACP3 species is only ∼0.4 ppm [51].
Furthermore, we found that the magnitude of shift changes
between apo and holo mACP9 did not depend in a straightforward
way on distance from the point of attachment of the prosthetic
group.
We therefore modified the Ppant thiol group of holo mACP9
with a nitroxide spin label to determine whether PRE experiments
could provide complementary information. As the reduced,
diamagnetic form of MTSL-mACP9 shows no 1HN/15N shift
perturbations from the holo species larger than 0.1 ppm
(Figure 7B), we deduced that the motional properties of the
prosthetic group are altered only to a minor extent by addition
of the spin label. In [1H,15N]-HSQC spectra of the oxidized,
paramagnetic form of MTSL-mACP9, all amide signals from
sites close to Ser2096 either disappear or are strongly broadened
(Figure 7C). It is not possible to interpret completely bleached
signals in fine-grained detail, but we take the clustering of residues
that experience substantial intensity reductions (Figure 7H) as
an indication that each site is transiently approached by the
paramagnetic centre to within 10 Å [40]. This result is consistent
with the Ppant arm sampling a wide range of conformations in
an isotropic manner, as would be expected for freely swinging
motion. Similar conclusions were drawn in recent studies of an
MTSL-modified holo peptidyl carrier protein from a teicoplanin-
producing NRPS system [47].
In common with the structure of rat FAS ACP [14], apo
mACP9 lacks an obvious central cavity, meaning that considerable
rearrangement would be required to bury an acyl group in
its hydrophobic core, in the style of type II carrier proteins
[11]. When the holo form of rat FAS ACP was compared with
species loaded with hexanoyl and palmitoyl chains, no 1HN/15N
shift changes >0.05 ppm and no acyl-protein NOEs could be
detected, leading to the conclusion that this type I domain does
not sequester long hydrophobic chains from the solvent [14].
Likewise, no δav values >0.13 ppm were found between the
holo and propionyl-, malonyl-, butyryl-, crotonyl- or hexanoyl-
loaded species of eryACP2 [16]. Derivatization of mACP9 with
C3 and C4 acyl chains has a similar outcome, with no δav
values >0.15 ppm (Figure 4), suggesting that these substrate
mimics remain predominantly exposed to the solvent. In contrast,
weighted shift changes >0.5 ppm are apparent for both hexanoyl-
and octanoyl-mACP9 species, alongside 26 NOE connections
between the octanoyl chain and the protein surface.
The ensemble of solution structures determined for octanoyl-
mACP9 shows the Ppant arm curling over to allow the acyl chain to
nestle into a nonpolar pocket formed between the α2′ and α3′ turns
and helix α2, whereas the prosthetic group itself remains solvent
exposed (Figure 5A). This behaviour is similar to that observed
for the ACP domain from the actinorhodin type II PKS (actACP),
with no significant interactions detected between the protein and
acetyl, malonyl, 3-oxobutyl or 3,5-dioxohexyl chains, but with
large shift changes apparent for nonpolar butyryl, hexanoyl and
octanoyl chains, yielding solution structures that showed Ppant
and the acyl moieties rigidly docked into a groove between the
α3′ turn and helices α2 and α3 (Figure 5B) [45]. For octanoyl-
mACP9, the interaction of the acyl chain with the protein surface
is clearly more superficial than that for octanoyl-actACP, which
in turn does not penetrate as deeply into the hydrophobic core
as seen in studies of octanoyl-ACP from the S. coelicolor type II
FAS (Figure 5C) [12]. Furthermore, in the ensemble of structures
for octanoyl-mACP9, the conformation of the Ppant moiety is
relatively uncertain (RMSD 3.4 Å), implying that it retains a
degree of flexibility analogous to that measured here for the major
and minor states of ATSL-mACP9 (Table 2). This behaviour is
different to the more precise definition of the prosthetic group in
the octanoyl-actACP ensemble (RMSD 1.7 Å), which is restrained
by 50 intra-Ppant, 12 Ppant-protein and 30 acyl-protein NOEs
[45].
The NOE connection between a pair of nuclear spins
corresponds to an r − 6-weighted time and ensemble average over
all the inter-nuclear distances sampled during the mixing time of a
NOESY experiment [52]. This strong distance dependence rarely
complicates the interpretation of NOE-based structures for folded
protein domains, but it implies that structures of more dynamic
systems may be biased towards conformations in which the two
spins are close in space, even if these are populated sparsely and
for relatively brief time periods. In this light, the ensemble of
solution structures for octanoyl-mACP9 should be regarded as a
collection of snapshots of bound conformations that provide no
information about potential unbound states in which the acyl chain
is fully exposed to solvent.
If a conformation in which a Ppant-tethered octanoyl group
is bound to the surface of an ACP domain is highly populated,
acyl-loading might be expected to stabilize the structure of the
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protein compared with the holo state, making it more resistant
to thermal denaturation. To our surprise, when we used circular
dichroism spectroscopy to monitor the unfolding of apo, holo,
hexanoyl- and octanoyl-mACP9 species, acyl group attachment
was found to have minimal effects on the melting temperature.
By contrast, modification with Ppant increased the melting
temperature of apo mACP9 by 6 K (Supplementary Figure S17).
Phosphopantetheinylation of the apo state of pf ACP has been
reported to cause a similar degree of stabilization, attributed to
the formation of hydrophobic contacts between the prosthetic
group and the protein surface [41]. In our hands, the Ppant group
of holo mACP9 appears to swing freely around its attachment
point, which suggests that other factors must be responsible for
increasing its resistance to denaturation. Further studies will be
needed to fully explain the effects of Ppant attachment on ACP
domain thermostability, but the results of our NMR and circular
dichroism experiments on octanoyl-mACP9 are consistent with its
acyl chain making weak transitory interactions with the surface
of the carrier protein.
Within the mycolactone PKS system, four other extender
module ACP domains display >95% identity with mACP9:
those from the third, seventh and eighth modules of MLSA1 and
the seventh module of MLSB [25]. When mACP9 is included,
this family of domains can be loaded with either malonyl or
methylmalonyl extender units, whereas its natural substrate chains
range in length from C8 to C20, can either possess or lack an
α-branching methyl group, and can sample three of the four
possible β-position oxidation states: an alcohol, an alkene or
a fully reduced methylene group (Supplementary Figure S20).
Compared with such diversity, this work has been able to
characterize a limited panel of commercially available substrate-
mimics (Supplementary Figure S16). Nevertheless, we have
shown that when attached to a type I PKS ACP fragment short
polar acyl chains remain exposed to the solvent, whereas longer,
more saturated chains can interact (albeit transiently) with patches
on the surface of the domain without significantly changing the
structure of the protein.
In the context of an intact PKS module, our observations
argue against channelling mechanisms that rely on substantial
substrate-mediated structural modifications to optimize the shape
of the ACP in such a way that protein–protein interactions with
accessible partner domains are promoted, whereas others are
prohibited. Alternatively, if the next destination of the ACP is to
be decided by random diffusion between a pre-selected subset
of partner domains [10] followed by recognition of substrate
chemistry alone, this would presumably be favoured by arranging
for solvent exposed acyl cargoes to be presented by highly
dynamic Ppant arms. Despite an apparent concordance between
this mechanism and our results for short polar substrate-mimics,
the sub-states identified in cryo-EM experiments on Pik module 5
suggest that both protein–protein interfaces and correct substrate
chemistry are required for the ACP to find an appropriate active
site [20,21]. Unfortunately, the >7 Å resolution of these cryo-EM
studies was not sufficient to localize any Ppant or acyl moieties, so
the relative importance of interactions with the ACP surface, the
prosthetic group or the substrate itself has not yet been established
for any of the detected sub-states.
Although not obtained using a natural substrate, our findings
for octanoyl-mACP9 pose the intriguing possibility that a partner
domain may be able to recognize an acyl group whereas it is
bound to the surface of its carrier protein, allowing simultaneous
interactions with both the substrate and the ACP. Subtle variations
in the substrate chemistry, ACP-docked conformation and features
of the adjacent ACP surface could then favour encounters with the
correct partner in order to facilitate progress through the reaction
cycle. From this perspective, the apparent flexibility of the Ppant
and acyl portions of octanoyl-mACP9 need not be seen as a
disadvantage, as a conformational selection mechanism triggered
by proximity to the cognate surface of a partner domain could
permit the substrate/Ppant/ACP interface to adapt so as to promote
productive interactions with the appropriate active site. Similar
mechanisms have recently been suggested for substrate-loaded
NRPS aryl and peptidyl carrier protein domains from the Type I
yersiniabactin [18] and the Type II pyoluteorin [19] systems.
Various novel methods have been used to investigate Ppant
behaviour, including the attachment of solvatochromic groups for
fluorescence spectroscopy [53], a cyanyl group for vibrational
spectroscopy [54] and fluorophenyl [55] or trifluoromethyl
[16] substituted acyl groups for 19F NMR spectroscopy. These
approaches were primarily designed to sense whether the probe
was buried in a nonpolar environment or exposed to solvent,
and do not return information about Ppant dynamics or details
about any detected site of interaction. Moreover, all three methods
require covalent modification of the Ppant arm, making them
incompatible with studies of natural acyl-ACP species, as well as
potentially perturbing the dynamics and interaction motifs of the
prosthetic group. This work has deployed NOE-based structure
determination, 1HN/15N chemical shift perturbation, nuclear spin
relaxation and PRE as a suite of tools that in combination can
report directly on the conformational and dynamic properties
of ACP-attached and substrate-loaded Ppant groups. Having
demonstrated that the Ppant arm in some circumstances swings
freely, but in others is ‘sticky’ enough to interact with the surface
of the carrier protein, the logical next step is to characterize the role
of prosthetic group dynamics in binary interactions between ACP
and partner domain fragments and within an intact PKS module.
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